Unjoni Ewropea - Malti - EMA (European Medicines Agency)

allergan pharmaceuticals international limited - eluxadoline - irritable bowel syndrome; diarrhea - antidiarrheals, intestinali anti-infjammatorji / antiinfective aġenti - truberzi huwa indikat fl-adulti għat-trattament tas-sindromu tal-musrana irritabbli bid-dijarea (ibs d).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

abbvie ltd - dasabuvir sodium - epatite Ċ, kronika - antivirali għal użu sistemiku - exviera huwa indikat flimkien ma 'prodotti mediċinali oħra għall-kura ta' l-epatite Ċ kronika (chc) fl-adulti. għall-vajrus tal-epatite Ċ (hcv) ġenotip attività speċifika.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sonidegib difosfat - karċinoma, Ċellula basal - aġenti antineoplastiċi - odomzo huwa indikat għat-trattament ta 'pazjenti adulti b'karċinoma taċ-ċelluli bażali lokalment avvanzati (bcc) li mhumiex suġġetti għal kirurġija ta' kura jew terapija bir-radjazzjoni.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

passauer pharma gmbh - mycophenolate mofetil - rifjut ta 'graft - immunosoppressanti - myclausen hija indikata fil kombinazzjoni ma ' ciclosporin u corticosteroids għall-profilassi ta ' rifjut transplant akuta fil-pazjenti li jirċievu trapjanti renali, kardijaċi jew epatiċi alloġenejċi.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

roche registration gmbh - mycophenolate mofetil - rifjut ta 'graft - immunosoppressanti - cellcept huwa indikat flimkien ma 'ciclosporin u kortikosterojdi għall-profilassi ta' rifjut akut ta 'trapjant f'pazjenti li qed jirċievu trapjanti alloġeniċi renali, tal-qalb jew tal-fwied.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

eli lilly and company limited  - fentanyl - sistema nervuża - klieb - għall-kontroll ta 'uġigħ assoċjat ma' kirurġija ortopedika u tessut artab fil-klieb.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

janssen-cilag international nv - simeprevir - epatite Ċ, kronika - antivirali għal użu sistemiku - olysio huwa indikat flimkien ma 'prodotti mediċinali oħra għall-kura ta' l-epatite Ċ kronika (chc) f'pazjenti adulti. għall-vajrus tal-epatite Ċ (hcv) ġenotip attività speċifika.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - thalidomide - majloma multipla - immunosoppressanti - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

lipomed gmbh - thalidomide - majloma multipla - immunosoppressanti - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - rikombinanti, l-istomatite stomatite virus (razza indiana) bi tħassir tal-pakkett glycoprotein, sostitwit bl-zaire ebolavirus (razza kikwit 1995) tal-wiċċ glycoprotein - emorraġiku-deni, l-ebola - vaċċini - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. l-użu ta ervebo għandha tkun skond ir-rakkomandazzjonijiet uffiċjali.